Abstract

Scoparone (6,7-dimethoxycoumarin) is a simple coumarin from botanical drugs of Artemisia species used in Traditional Chinese Medicine and Génépi liquor. However, its bioavailability to the brain and potential central effects remain unexplored. We profiled the neuropharmacological effects of scoparone upon acute and subchronic intraperitoneal administration (2.5–25 mg/kg) in Swiss mice and determined its brain concentrations and its effects on the endocannabinoid system (ECS) and related lipids using LC–ESI–MS/MS. Scoparone showed no effect in the forced swimming test (FST) but, administered acutely, led to a bell-shaped anxiogenic-like behavior in the elevated plus-maze test and bell-shaped procognitive effects in the passive avoidance test when given subchronically and acutely. Scoparone rapidly but moderately accumulated in the brain (Cmax < 15 min) with an apparent first-order elimination (95% eliminated at 1 h). Acute scoparone administration (5 mg/kg) significantly increased brain arachidonic acid, prostaglandins, and N-acylethanolamines (NAEs) in the FST. Conversely, subchronic scoparone treatment (2.5 mg/kg) decreased NAEs and increased 2-arachidonoylglycerol. Scoparone differentially impacted ECS lipid remodeling in the brain independent of serine hydrolase modulation. Overall, the unexpectedly potent central effects of scoparone observed in mice could have toxicopharmacological implications for humans.

Highlights

  • Scoparone (6,7-dimethoxycoumarin) is a simple coumarin from botanical drugs of Artemisia species used in Traditional Chinese Medicine and Génépi liquor

  • A post-hoc analysis showed that scoparone at the doses of 2.5, 5 (p < 0.05), and 25 mg/kg (p < 0.01) significantly decreased the percentage of the time spent on the open arms as well as the percentage of open arm entries, indicating an anxiety-like behavior

  • Upon subchronic treatment, scoparone did not show any effect in the elevated plus-maze (EPM) at the doses 2.5, 5, 12.5, and 25 mg/kg (Supplementary Table S4)

Read more

Summary

Introduction

Scoparone (6,7-dimethoxycoumarin) is a simple coumarin from botanical drugs of Artemisia species used in Traditional Chinese Medicine and Génépi liquor. We profiled the neuropharmacological effects of scoparone upon acute and subchronic intraperitoneal administration (2.5–25 mg/kg) in Swiss mice and determined its brain concentrations and its effects on the endocannabinoid system (ECS) and related lipids using LC–ESI–MS/MS. We assessed the neuropharmacological effects of scoparone (Fig. 1) in a test battery of complex behavioral paradigms, including (a) depression-like behavior in the forced swim test (FST), Scientific Reports | (2022) 12:822. (b) anxiety-like behavior in the elevated plus-maze (EPM), and (c) learning and memory in the passive avoidance test (PA) after acute and subchronic, (i.p.) injections of scoparone (2.5–25 mg/kg) in Swiss albino mice. The PA paradigm was applied to assess scoparone’s procognitive/neuroprotective effects in both lipopolysaccharide (LPS) and scopolamine-induced mouse impaired learning and ­memory[13,14]

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.